← Back to headlines
AEON Biopharma Reports GAAP EPS of -$0.29
AEON Biopharma announced its latest financial results, reporting a GAAP Earnings Per Share (EPS) of -$0.29.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
